Invitro psoriasis models with focus on reconstructed skin models as promising tools in psoriasis research

被引:52
作者
Desmet, Eline [1 ]
Ramadhas, Anesh [1 ]
Lambert, Jo [1 ]
Van Gele, Mireille [1 ]
机构
[1] Ghent Univ Hosp, Dept Dermatol, B-9000 Ghent, Belgium
关键词
Dermatology; psoriasis; keratinocytes; skin equivalents; tissue engineering; drug testing; HUMAN KERATINOCYTES; T-CELLS; EPIDERMAL DIFFERENTIATION; EQUIVALENT TISSUE; VULGARIS LESIONS; DEFINED MEDIUM; FIBROBLASTS; COLLAGEN; EXPRESSION; CYTOKINES;
D O I
10.1177/1535370217710637
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Psoriasis is a complex chronic immune-mediated inflammatory cutaneous disease associated with the development of inflammatory plaques on the skin. Studies proved that the disease results from a deregulated interplay between skin keratinocytes, immune cells and the environment leading to a persisting inflammatory process modulated by pro-inflammatory cytokines and activation of T cells. However, a major hindrance to study the pathogenesis of psoriasis more in depth and subsequent development of novel therapies is the lack of suitable pre-clinical models mimicking the complex phenotype of this skin disorder. Recent advances in and optimization of three-dimensional skin equivalent models have made them attractive and promising alternatives to the simplistic monolayer cultures, immunological different invivo models and scarce ex vivo skin explants. Moreover, human skin equivalents are increasing in complexity level to match human biology as closely as possible. Here, we critically review the different types of three-dimensional skin models of psoriasis with relevance to their application potential and advantages over other models. This will guide researchers in choosing the most suitable psoriasis skin model for therapeutic drug testing (including gene therapy via siRNA molecules), or to examine biological features contributing to the pathology of psoriasis. However, the addition of T cells (as recently applied to a de-epidermized dermis-based psoriatic skin model) or other immune cells would make them even more attractive models and broaden their application potential. Eventually, the ultimate goal would be to substitute animal models by three-dimensional psoriatic skin models in the pre-clinical phases of anti-psoriasis candidate drugs.
引用
收藏
页码:1158 / 1169
页数:12
相关论文
共 105 条
[1]   Identification of avarol derivatives as potential antipsoriatic drugs using an in vitro model for keratinocyte growth and differentiation [J].
Amigo, Maria ;
Schalkwijk, Joost ;
Olthuis, Diana ;
De Rosa, Salvatore ;
Paya, Miguel ;
Terencio, Maria Carmen ;
Lamme, Evert .
LIFE SCIENCES, 2006, 79 (25) :2395-2404
[2]   The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-γ, interleukin-2, and tumor necrosis factor-α, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations:: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients [J].
Austin, LM ;
Ozawa, M ;
Kikuchi, T ;
Walters, IB ;
Krueger, JG .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (05) :752-759
[3]   Behaviour of Endothelial Cells in a Tridimensional In Vitro Environment [J].
Ayata, Raif Eren ;
Chabaud, Stephane ;
Auger, Michele ;
Pouliot, Roxane .
BIOMED RESEARCH INTERNATIONAL, 2015, 2015
[4]  
Ayehunie S, 2016, SOC INV DERM M
[5]  
Ayehunie S, 2012, SOC INV DERM M
[6]  
Ayehunie S, 2011, SOC INV DERM M
[7]   The development and characterization of an in vitro model of psoriasis [J].
Barker, CL ;
McHale, MT ;
Gillies, AK ;
Waller, J ;
Pearce, DM ;
Osborne, J ;
Hutchinson, PE ;
Smith, GM ;
Pringle, JH .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 123 (05) :892-901
[8]   LIVING TISSUE FORMED INVITRO AND ACCEPTED AS SKIN-EQUIVALENT TISSUE OF FULL THICKNESS [J].
BELL, E ;
EHRLICH, HP ;
BUTTLE, DJ ;
NAKATSUJI, T .
SCIENCE, 1981, 211 (4486) :1052-1054
[9]   In vitro 3D Full-Thickness Skin-Equivalent Tissue Model Using Silk and Collagen Biomaterials [J].
Bellas, Evangelia ;
Seiberg, Miri ;
Garlick, Jonathan ;
Kaplan, David L. .
MACROMOLECULAR BIOSCIENCE, 2012, 12 (12) :1627-1636
[10]  
Bernard FX, 2012, J ALLERGY, V2012